Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice

Virology

Volumn 276, Issue 1, 2000, Pages 93-103

  Bernard, K A ^a   Klimstra, W B ^a   Johnston, R E ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E2; HEPARAN SULFATE; HEPARIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHO CELL; EPIDEMIC; MOUSE; NONHUMAN; PRIORITY JOURNAL; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS ENCEPHALITIS; VIRUS INFECTIVITY; VIRUS MUTANT;

EID: 0034633834     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0546     Document Type: Article

References (82)

1. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus
2. Effect of heparin on infection of cells by equine arteritis virus
3. Multiple virulence determinants of foot-and-mouth disease virus in cell culture
4. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells
5. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
6. Binding of Sindbis virus to cell surface heparan sulfate
7. Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation
8. Molecular modeling of protein-glycosaminoglycan interactions
9. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
10. A27L protein mediated vaccinia virus interaction with cell surface heparan sulfate
11. FACS-optimized mutants of the green fluorescent protein (GFP)
12. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
13. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1
14. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone
15. In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: Analysis of a viable deletion mutant
16. The systemic pathology of Venezuelan equine encephalitis virus infection in humans
17. Rapid selection in modified BHK-21 cells of a foot-and-mouth disease virus variant showing alterations in cell tropism
18. Animal cell mutants defective in glycosaminoglycan biosynthesis
19. Biochemical and antigenic comparison of the envelope glycoproteins of Venezuelan equine encephalomyelitis virus strains
20. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex
21. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor
22. The comparative pathology of experimental Venezuelan equine encephalomyelitis virus infection in different animal hosts
23. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins
24. Glycosaminoglycan-protein interactions: Definition of consensus sites in glycosaminoglycan binding proteins
25. Cell-surface heparan sulfate facilities human immunodeficiency virus type 1 entry into some cell lines but not primary lymphocytes
26. Efficient infection of cells in culture by type O foot and mouth disease virus requires binding to cell surface heparan sulfate
27. Virulence heterogeneity of a predominantly avirulent Western equine encephalitis virus population
28. Comparisons among members of the Venezuelan encephalitis virus complex using hydroxylapatite column chromatography
29. Selective clearance of a benign clone of Venezuelan equine encephalitis virus from hamster plasma by hepatic reticuloendothelial cells
30. Evaluation of vascular clearance as a marker for virulence of alphaviruses: Disassociation of rapid clearance with low virulence of Venezuelan encephalitis virus strains in guinea pigs
31. Vascular clearance of Venezuelan equine encephalomyelitis viruses as a correlate to virulence for rhesus monkeys
32. Histopathology and distribution of viral antigens in hamsters infected with virulent and benign Venezuelan equine encephalitis viruses
33. Growth curves and clearance rates of virulent and benign Venezuelan encephalitis viruses in hamsters
34. Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein
35. Selection for accelerated penetration in cell culture coselects for attenuated mutants of Venezuelan equine encephalitis virus
36. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes
37. Effect of heparin on infection of cells by porcine reproductive and respiratory syndrome virus
38. A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope
39. Plasma clearance of human extracellular-superoxide dismutase C in rabbits
40. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein
41. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83
42. Molecular evidence for the origin of the widespread Venezuelan equine encephalitis epizootic of 1969 to 1972
43. Proteoglycans: Structures and interactions
44. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor
45. Infection of neonatal mice with Sindbis virus results in a systemic inflammatory response syndrome
46. Heparin-dependent attachment of respiratory syncytial virus (RSV) to cells
47. A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis
48. A putative receptor for Venezuelan equine encephalitis virus from mosquito cells
49. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis
50. Correlation between virus-cell receptor properties of alphaviruses in vitro and virulence in vivo
51. Effect of polyions on the early events of Sindbis virus infection of Vero cells
52. Interaction of glycoprotein gcIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus
53. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family
54. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor
55. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate
56. BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface
57. Three-dimensional structure of a membrane-containing virus
58. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines
59. Two variants of Sindbis virus which differ in interferon induction and serum clearance. I. The phenomenon
60. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo
61. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
62. Association of sindbis virion glycoproteins and their precursors
63. In vitro mechanisms of monoclonal antibody neutralization of alphaviruses
64. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle
65. Two variants of Sindbis virus which differ in interferon induction and serum clearance. II. Virological characterizations
66. Molecular evidence that epizootic Venezuelan equine encephalitis (VEE) I-AB viruses are not evolutionary derivatives of enzootic vee subtype I-E or II viruses
67. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor
68. Entry of alphaherpesviruses into cells
69. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins
70. AlphaVbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection
71. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
72. Attachment of the gammaherpesvirus bovine herpesvirus 4 is mediated by the interaction of gp8 glycoprotein with heparinlike moieties on the cell surface
73. The comparative pathology of Venezuelan equine encephalomyelitis
74. Hepatic and extrahepatic uptake of intravenously injected lipoprotein lipase
75. Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor
76. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells
77. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus
78. Electron microscopic analysis of infection patterns for Venezuelan equine encephalomyelitis virus in the vector mosquito, Culex (Melanoconion) taeniopus
79. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
80. Metabolism of the intravenously administered recombinant human basic fibroblast growth factor, trafermin, in liver and kidney: Degradation implicated in its selective localization to the fenestrated type microvasculatures
81. Heparin protein interactions